Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Role of ROR-alpha in Type-2 Innate Lymphocyte Lineage Selection and Type-2 Inflammation
EF 2012-13
Résumé
Allergic lung inflammation and asthma are leading causes of morbidity and mortality in children and adults. In Canada alone, over 2.5 million people suffer from asthma. Type-2 Innate Lymphoid (ILC2) cells were recently discovered to be critically important in mediating inflammation in the lung and intestines. Normally ILC2 cells play a role in fighting parasite infections, but in mice and humans they can also be activated by allergens, causing unwanted allergic inflammation in the lung. We have now discovered that the gene Rora is required for ILC2 cell development, because mice that lack Rora do not have ILC2 cells. More importantly, these mice also don't develop allergic lung inflammation, thus proving the inflammatory role of ILC2 cells. My project is designed to discover how the gene Rora is needed for ILC2 cell development, and if we can target Rora in fighting lung inflammation or asthma. The method I intend to use allows me to track cells where Rora is turned on, which include mature and immature ILC2 cells. This is important because the detection of Rora and ILC2 cells is currently very difficult. Furthermore, I will study lung inflammation in mice where Rora has been turned off in only some immune cells, which is important for detailed analysis of ILC2 cells. This is of great importance to scientists in Canada and around the world, as little is known about the function and development of ILC2 cells. Lastly, I will target Rora with compounds designed to inhibit its function. For many years it was believed that other cells were important for lung inflammation and asthma, resulting in drugs designed towards these cells. However, my findings suggest that ILC2 cells play a leading part in lung inflammation. I predict that by targeting Rora we can inhibit the development or function of ILC2 cells, which should have a positive effect on lung inflammation and asthma. These compounds could potentially be developed as future drugs for inflammatory diseases.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
273317
Name
Halim Timotheus Y
Country
United Kingdom
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Role of ROR-alpha in Type-2 Innate Lymphocyte Lineage Selection and Type-2 Inflammation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Allergic Lung Inflammation And Asthma; Development Of The Immune System; Drug Discovery; Facs/Flow Cytometry; Gene Expression Analysis; Gene-Reporter Mouse; Haematopoiesis; Immune Regulation; Small Molecule Inhibitors
Abstract
Allergic lung inflammation and asthma are leading causes of morbidity and mortality in children and adults. In Canada alone, over 2.5 million people suffer from asthma. Type-2 Innate Lymphoid (ILC2) cells were recently discovered to be critically important in mediating inflammation in the lung and intestines. Normally ILC2 cells play a role in fighting parasite infections, but in mice and humans they can also be activated by allergens, causing unwanted allergic inflammation in the lung. We have now discovered that the gene Rora is required for ILC2 cell development, because mice that lack Rora do not have ILC2 cells. More importantly, these mice also don't develop allergic lung inflammation, thus proving the inflammatory role of ILC2 cells. My project is designed to discover how the gene Rora is needed for ILC2 cell development, and if we can target Rora in fighting lung inflammation or asthma. The method I intend to use allows me to track cells where Rora is turned on, which include mature and immature ILC2 cells. This is important because the detection of Rora and ILC2 cells is currently very difficult. Furthermore, I will study lung inflammation in mice where Rora has been turned off in only some immune cells, which is important for detailed analysis of ILC2 cells. This is of great importance to scientists in Canada and around the world, as little is known about the function and development of ILC2 cells. Lastly, I will target Rora with compounds designed to inhibit its function. For many years it was believed that other cells were important for lung inflammation and asthma, resulting in drugs designed towards these cells. However, my findings suggest that ILC2 cells play a leading part in lung inflammation. I predict that by targeting Rora we can inhibit the development or function of ILC2 cells, which should have a positive effect on lung inflammation and asthma. These compounds could potentially be developed as future drugs for inflammatory diseases.
Competitiondate
201211
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Halim, Timotheus Y
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~